|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endoscopic ultrasound-guided vs endoscopic retrograde cholangiopancreatography biliary drainage for obstructed distal malignant biliary strictures: A systematic review and meta-analysis显示文摘BACKGROUND For palliation of malignant biliary obstruction(MBO), the gold-standard method of biliary drainage is endoscopic retrograde cholangiopancreatography(ERCP)with the placement of metallic stents. Endoscopic ultrasound(EUS)-guided drainage is an alternative that is typically reserved for cases of ERCP failure.Recently, however, there have been robust randomized clinical trials(RCTs)comparing EUS-guided drainage and ERCP as primary approaches to MBO.AIM To compare EUS guidance and ERCP in terms of their effectiveness and safety in palliative biliary drainage for MBO.METHODS This was a systematic review and meta-analysis, in which we searched the MEDLINE, Excerpta Medica, and Cochrane Central Register of Controlled Trials databases. Only RCTs comparing EUS and ERCP for primary drainage of MBO were eligible. All of the studies selected provided data regarding the rates of technical and clinical success, as well as the duration of the procedure, adverse events, and stent patency. We assessed the risk of biases using the Jadad score and the quality of evidence using the Grading of Recommendations Assessment,Development and Evaluation criteria.RESULTS The database searches yielded 5920 records, from which we selected 3 RCTs involving a total of 222 patients(112 submitted to EUS and 110 submitted to ERCP). In the EUS and ERCP groups, the rate of technical success was 91.96%n and 91.81%, respectively, with a risk difference(RD) of 0.00%(95%CI:-0.07, 0.07;P = 0.97; I^2 = 0%). The clinical success was 84.81% and 85.53% in the EUS and ERCP groups, respectively, with an RD of-0.01%(95%CI:-0.12, 0.10; P = 0.90; I^2 =0%). The mean difference(MD) for the duration of the procedure was-0.12%(95%CI:-8.20, 7.97; P = 0.98; I^2 = 84%). In the EUS and ERCP groups, there were14 and 25 adverse events, respectively, with an RD of-0.06%(95%CI:-0.23, 0.12; P= 0.54; I^2 = 77%). The MD for stent patency was 9.32%(95%CI:-4.53, 23.18; P =0.19; I^2 = 44%). The stent dysfunction rate was significantly lower in the EUS t group(MD =-0.22%; 95 CI:-0.35,-0.08; P = 0.001; I^2 = 0%).CONCLUSION EUS represents an interesting alternative to ERCP for MBO drainage,demonstrating lower stent dysfunction rates compared with ERCP. Technical and clinical success, duration, adverse events and patency rates were similar. | Fernanda P Logiudice Wanderlei M Bernardo Facundo Galetti Vitor M Sagae Carolina O Matsubayashi Antonio C Madruga Neto Vitor O Brunaldi Diogo T H de Moura Tomazo Franzini Spencer Cheng Sergio E Matuguma Eduardo G H de Moura | 2019 | World Journal of Gastrointestinal Endoscopy2019，11，4： | 6 |
| 2 | A Meta analysis of some results of clinical trials on sulodexide therapy in pc ripheral occlusive arterial disease显示文摘 | Gaddi A Galetti C Mumiuti B | 1996 | Int Med Res1996，24，3： | 1 |
| 3 | Results of contemporary radical cystectomy for invasive bladder cancer:a clinicopathological study with an emphasis on the inadequacy of the tumor,nodes and metastases classification显示文摘 | Pagano F Bassi P Galetti TP | 1991 | J Urol1991，145，1： | 1 |
| 4 | Dose-dependent effect of FHIT-inducible expression in Catu-1 lung cancer cell line显示文摘 | Cavazzoni A Petronini PG Galetti M | 2004 | Oncogene2004，23，52： | 1 |
| 5 | Sea-water battery for subsea control systems显示文摘 | HASVOLD Q HENRIKSEN H MELVAX E CITI G JOHANSEN B KJONIGSEN T GALETTI R | 1997 | Journal of Power Sources1997，65，： | 1 |
| 6 | Relationships between hydrophobicity,reactivity,accumulation and peripheral nerve toxicity of a series of platinum drugs显示文摘 | Screnci D McKeage MJ Galettis P | 2000 | Br J Cancer2000，82，4： | 1 |
| 7 | Intercellular adhesion mole- cule-1 (ICAM-1) expression is necessary for monocyte adhesion to the placental bed endothelium and is increased in type 1 dia- betic human pregnancy显示文摘 | Xie B Galettis A Morris J | 2008 | Diabetes Metab Res Rev2008，24，4： | 1 |
| 8 | Anti- mycobacterlal and cytotoxieity activity of synthetic and natural compounds 显示文摘 | De Souza A O Galetti F C S Silva C L | 2007 | Quire Nova2007，30，7： | 1 |
| 9 | Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines显示文摘 | La Monica S Galetti M Alfieri RR | | 0，，05： | 1 |
| 10 | Synaptonemal complex analysis in spermatocytes of tilapia Oreochromis niloticus(Pisces:Cichlidae)显示文摘 | Oliviera C Galetti P M | 1993 | Genome1993，36，： | 1 |
| 11 | Population pharmaeokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate显示文摘 | Jiang X Galettis P Links M | 2008 | Br J Clin Pharmacol2008，65，3： | 1 |
| 12 | In vitro antitumour and hepatotoxicity profiles of Au (I) and Ag (I) bidentate pyri?dyl phosphine complexes and relationships to cellular uptake显示文摘 | Liu J J Galettis P FaIT A | 2008 | J Inorg Biochem2008，102，2： | 1 |
| 13 | Endoscopic ultrasonograpy: current clinical role 显示文摘 | Fusaloli P Galetti G | 2005 | Eur J Gastroenterol Heptol2005，17，3： | 1 |
| 14 | Modified constraint-induced movement therapy and modified forced-use therapy for stroke patients are both effective to promote balance and gait improvements显示文摘 | Fuzaro AC Guerreiro CT Galetti FC | 2012 | Rev Bras Fi-sioter2012，16，2： | 1 |
| 15 | Iodine intake as a risk factor for thyroid cancer: A comprehensive review of animal and human studies 显示文摘 | Zimmermann NB Galetti V | 2015 | Thyroid Res2015，8，： | 1 |
| 16 | Chromosomal studies in south atlantic serranids(Pisces,Perciformes)显示文摘 | De Aguilar C T Galetti P M | 1997 | Cytobios1997，89，： | 1 |
| 17 | Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines显示文摘 | La Monica S Galetti M Alfieri RR Cavazzoni A Ardizzoni A Tiseo M | 2009 | Biochem Pharmacol2009，78，5： | 1 |
| 18 | RAPD analysis in the Neotropical fish Brycon lundii : genetic diversity and its implications for the conservation of the species 显示文摘 | Pinto W A Galetti Jr P M | 2002 | Hydrobiologia2002，474，： | 1 |
| 19 | Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines 显示文摘 | La Monica S Galetti M Alfieri RR | 2009 | Biochem Pharmacol2009，78，46： | 1 |
| 20 | Diet of the large fruit-eating bat Artibeus lituratus in a forest fragment in brasil显示文摘 | GALETTI M MORELLATO L P C | 1994 | Mammalia1994，58，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员